ACADIA Pharmaceuticals (ACAD)
|
6.00
+0.01 (+0.17%)
|
|
|
|
ACAD analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACAD price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
ACAD earnings
Date
Actual
Expected
Prev Yr Qtr
11/5/2012
-0.04
-0.09
-0.10
8/8/2012
-0.10
-0.12
-0.12
5/8/2012
-0.12
-0.11
-0.12
ACADIA Pharmaceuticals (ACAD) Upgrades
Date
Analyst
Old Rating
New Rating
07/08/2008
BofA
Sell
Neutral
12/12/2007
JMP Securities
Outperform
Strong Buy
ACADIA Pharmaceuticals (ACAD) Downgrades
Date
Analyst
Old Rating
New Rating
09/01/2009
Barclays Capital
Overweight
Equal Weight
09/01/2009
Citi
Hold
Sell
10/29/2008
Piper Jaffray
Neutral
Sell
08/06/2008
JMP Securities
Market Outperform
Market Perform
08/05/2008
Piper Jaffray
Buy
Neutral
06/17/2008
BofA
Buy
Sell
ACADIA Pharmaceuticals (ACAD) New Coverage
Date
Analyst
Rating
05/24/2012
Roth Capital
Buy
04/30/2012
Ladenburg Thalmann
Buy
